UnitedHealth Group Incorporated (NYSE:UNH) is Oak Ridge Investments LLC’s 10th Largest Position

Oak Ridge Investments LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 39,719 shares of the healthcare conglomerate’s stock after buying an additional 2,669 shares during the period. UnitedHealth Group comprises about 2.0% of Oak Ridge Investments LLC’s portfolio, making the stock its 10th largest holding. Oak Ridge Investments LLC’s holdings in UnitedHealth Group were worth $23,223,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of UNH. Reston Wealth Management LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at $119,000. Baron Silver Stevens Financial Advisors LLC boosted its position in shares of UnitedHealth Group by 7.3% during the 3rd quarter. Baron Silver Stevens Financial Advisors LLC now owns 735 shares of the healthcare conglomerate’s stock valued at $430,000 after acquiring an additional 50 shares during the last quarter. Cordatus Wealth Management LLC boosted its position in shares of UnitedHealth Group by 0.5% during the 3rd quarter. Cordatus Wealth Management LLC now owns 10,031 shares of the healthcare conglomerate’s stock valued at $5,865,000 after acquiring an additional 46 shares during the last quarter. AustralianSuper Pty Ltd boosted its position in shares of UnitedHealth Group by 28.7% during the 3rd quarter. AustralianSuper Pty Ltd now owns 556,896 shares of the healthcare conglomerate’s stock valued at $325,606,000 after acquiring an additional 124,068 shares during the last quarter. Finally, Rosenberg Matthew Hamilton raised its holdings in UnitedHealth Group by 3.7% in the 3rd quarter. Rosenberg Matthew Hamilton now owns 878 shares of the healthcare conglomerate’s stock valued at $514,000 after buying an additional 31 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

NYSE:UNH opened at $564.40 on Friday. The business has a fifty day moving average of $582.30 and a 200-day moving average of $540.65. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The stock has a market cap of $521.18 billion, a price-to-earnings ratio of 36.77, a PEG ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the business earned $6.56 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Morgan Stanley cut their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Stephens dropped their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. Argus raised their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Finally, Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.